Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Maria Brown to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- University of Southern California/Norris Cancer Center, Los Angeles, California, 90033
- City of Hope South Pasadena, South Pasadena, California, 91030
- City of Hope, Duarte, California, 91010
- City of Hope Comprehensive Cancer Center, Duarte, California, 91010
- University of California at Davis Cancer Center, Sacramento, California, 95817
- University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817
Powered by
SC CTSI